Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma.
Li J, Qin C, Wu Y, Cheng S, Wang Y, Chen H, Chen F, Chen B, Li J.
Li J, et al. Among authors: chen b, chen f, chen h.
Front Mol Biosci. 2023 Dec 21;10:1300294. doi: 10.3389/fmolb.2023.1300294. eCollection 2023.
Front Mol Biosci. 2023.
PMID: 38192337
Free PMC article.